| Market Cap | 5.66B 4.96B 4.61B 4.23B 7.98B 546B 8.09B 54.87B 21.48B 267B 21.26B 20.8B 924B | P/E 2026 * |
48.3x | P/E 2027 * | 22.5x |
|---|---|---|---|---|---|
| Enterprise Value | 7.92B 6.94B 6.44B 5.92B 11.15B 764B 11.32B 76.73B 30.03B 374B 29.73B 29.08B 1,292B | EV / Sales 2026 * |
2.54x | EV / Sales 2027 * | 2.25x |
| Free-Float |
47.1% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Impax Laboratories Inc
| 1 day | -2.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
Chirag K. Patel
CEO | Chief Executive Officer | 59 | 2019-07-31 |
Chintu Patel
CEO | Chief Executive Officer | 54 | 2019-07-31 |
| Director of Finance/CFO | 58 | 2023-11-06 |
| Director | Title | Age | Since |
|---|---|---|---|
Deborah Autor
BRD | Director/Board Member | 59 | 2023-11-06 |
J. Buchi
BRD | Director/Board Member | 70 | 2023-11-06 |
Jeffrey George
BRD | Director/Board Member | 52 | 2023-11-06 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.00% | -2.92% | - | - | 5.66B | |
| -1.05% | +0.55% | +49.79% | +151.71% | 1,037B | |
| +2.00% | +3.49% | +52.22% | +50.20% | 615B | |
| -1.09% | +3.76% | +35.37% | +76.22% | 448B | |
| +1.64% | +1.99% | +29.43% | +23.66% | 326B | |
| -0.91% | +0.71% | +33.31% | +36.72% | 293B | |
| -1.03% | -0.54% | +17.66% | +16.51% | 264B | |
| -2.56% | -7.03% | -29.49% | -43.24% | 216B | |
| -0.05% | +2.16% | +19.75% | +55.89% | 198B | |
| +0.05% | -1.03% | +18.31% | +61.63% | 162B | |
| Average | -0.71% | +1.12% | +25.15% | +47.70% | 395.27B | |
| Weighted average by Cap. | -0.62% | +1.47% | +34.89% | +72.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.12B 2.73B 2.53B 2.33B 4.39B 301B 4.45B 30.19B 11.82B 147B 11.69B 11.44B 508B | 3.33B 2.92B 2.71B 2.49B 4.69B 321B 4.76B 32.26B 12.62B 157B 12.5B 12.23B 543B |
| Net income | 122M 107M 99.18M 91.14M 172M 11.77B 174M 1.18B 462M 5.76B 458M 448M 19.89B | 263M 231M 214M 197M 371M 25.39B 376M 2.55B 998M 12.42B 988M 967M 42.92B |
| Net Debt | 2.26B 1.98B 1.83B 1.69B 3.18B 218B 3.22B 21.86B 8.56B 107B 8.47B 8.29B 368B | 1.81B 1.59B 1.48B 1.36B 2.55B 175B 2.59B 17.57B 6.88B 85.62B 6.81B 6.66B 296B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
